p16INK4a (p16) is a cyclin-dependent kinase inhibitor that has been proven to be strongly overexpressed in transforming infections with oncogenic types of HPV and is believed to be a surrogate marker for precancerous cervical lesions [10, 11]. Here, CDKN2A is linked to infection.